Arş. Gör. Dr. ENDER DOĞAN

1. Validity and reliability of the Turkish version of the peace, equanimity, and acceptance in the cancer experience (PEACE) scale

Ödek Ö., Savaş M., ÇELİK H., Taşcl G., Doǧan E., ZİNCİR H.

Palliative and Supportive Care , cilt.23, 2025 (SSCI, Scopus)

2. The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing

KÖSTEK O., Demirel A., Hacıoğlu M. B., TAŞTEKİN D., KARABULUT S., Gündogdu A., et al.

Journal of Chemotherapy , cilt.36, sa.7, ss.613-621, 2024 (SCI-Expanded, Scopus)

3. Impact of prognostic factors on platinum response in extrapulmonary neuroendocrine carcinoma

DOĞAN E., FIRAT S. T., BUĞDAY İ., BOZKURT O., İNANÇ M., ÖZKAN M.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE , cilt.14, ss.279-282, 2023 (ESCI)

4. Two different characteristics and prognosis of grade 3 gastroenteropancreatic neuroendocrine tumors

DOĞAN E., ÖZKAN M., İNANÇ M., ABDÜLREZZAK Ü., TUTUŞ A., ÖZTÜRK F., et al.

Annals of Medical Research , cilt.30, sa.6, ss.666-670, 2023 (TRDizin)

5. Is SUVmax of 18F-FDG PET/CT Predictive Factor for Malignancy in Gastrointestinal Tract?

ÖZASLAN E., Kiziltepe M., Addulrezzak U., KULA M., BOZKURT O., Kut E., et al.

NIGERIAN JOURNAL OF CLINICAL PRACTICE , cilt.24, sa.8, ss.1217-1224, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey

Hacioglu M. B., Kostek O., Karabulut S., Tastekin D., SEZGİN GÖKSU S., Alandag C., et al.

JOURNAL OF BUON , cilt.25, sa.4, ss.1897-1903, 2020 (SCI-Expanded, Scopus)

7. Efficacy of second-line targeted agents in kras wild metastatic colorectal cancer patients who received prior targeted agent: First anti-epidermal growth factor receptor or vascular endothelial growth factor in right and left colon?

DOĞAN E., FIRAT S. T., COŞAR R., BOZKURT O., İNANÇ M., ÖZKAN M.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.4, ss.781-786, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy

Uskent N., AYLA Ş., Mandel N. M., ÖZKAN M., Teomete M., Baloglu H., et al.

JOURNAL OF ONCOLOGY , cilt.2020, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. The impact of lymphovascular invasion on recurrence-free survival in high-risk stage II colorectal cancer patients treated with adjuvant therapy.

Bozkurt O., Fırat S. T., Doğan E., İnanç M., Deniz K., Ertürk Zararsız G., et al.

Erciyes Medical Journal , cilt.41, sa.2, ss.191-195, 2019 (TRDizin)

10. Evaluation of DNA damage in patients with Neuroendocrine Tumor

HAMURCU Z., BAYRAM F., DELIBASI N., Öztürk F., DONMEZ-ALTUNTAS H., GÜRSOY Ş., et al.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , ss.1, 2019 (Scopus, TRDizin)

11. Role of Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Predictors for Survival in Metastatic Bladder Cancer Patients Receiving Fist-Line Chemotherapy

BOZKURT O., DOĞAN E., FIRAT S. T., COŞAR R., İNANÇ M., ERTÜRK ZARARSIZ G., et al.

ERCIYES MEDICAL JOURNAL , 2019 (ESCI, TRDizin)

12. Ipilimumab-associated cholestatic hepatitis: a case report and literature review

Yildirim S., DENİZ K., Dogan E., BAŞKOL M., GÜRSOY Ş., ÖZKAN M.

MELANOMA RESEARCH , cilt.27, sa.4, ss.380-382, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. The Serum YKL-40 Level is Associated with Vascular Injury and Predicts Proteinuria in Nephrotic Syndrome Patients

Kocyigit I., Gungor O., Dogan E., Karadavut S., Karakukcu C., EROĞLU E., et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS , cilt.22, sa.3, ss.257-264, 2015 (SCI-Expanded, Scopus)

14. Effects of Dialysis Solution on the Cardiovascular Function in Peritoneal Dialysis Patients

Kocyigit I., ÜNAL A., Gungor O., Orscelik O., EROĞLU E., Dogan E., et al.

INTERNAL MEDICINE , cilt.54, sa.1, ss.3-10, 2015 (SCI-Expanded, Scopus)

Arş. Gör. Dr. ENDER DOĞAN

Yayınlar & Eserler

1. Validity and reliability of the Turkish version of the peace, equanimity, and acceptance in the cancer experience (PEACE) scale

2. The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing

3. Impact of prognostic factors on platinum response in extrapulmonary neuroendocrine carcinoma

4. Two different characteristics and prognosis of grade 3 gastroenteropancreatic neuroendocrine tumors

5. Is SUVmax of 18F-FDG PET/CT Predictive Factor for Malignancy in Gastrointestinal Tract?

6. Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey

7. Efficacy of second-line targeted agents in kras wild metastatic colorectal cancer patients who received prior targeted agent: First anti-epidermal growth factor receptor or vascular endothelial growth factor in right and left colon?

8. Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy

9. The impact of lymphovascular invasion on recurrence-free survival in high-risk stage II colorectal cancer patients treated with adjuvant therapy.

10. Evaluation of DNA damage in patients with Neuroendocrine Tumor

11. Role of Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Predictors for Survival in Metastatic Bladder Cancer Patients Receiving Fist-Line Chemotherapy

12. Ipilimumab-associated cholestatic hepatitis: a case report and literature review

13. The Serum YKL-40 Level is Associated with Vascular Injury and Predicts Proteinuria in Nephrotic Syndrome Patients

14. Effects of Dialysis Solution on the Cardiovascular Function in Peritoneal Dialysis Patients

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Açık Erişim